Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function. 2006

Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
Section of Endocrinology, Dept. of Physiology and Pharmacology, Sahlgrenska Academy, Göteborg University, SE-40530, Gothenburg, Sweden. ruijin.shao@fysiologi.gu.se

Progesterone and its interaction with nuclear progesterone receptors (PR) PR-A and PR-B play a critical role in the regulation of female reproductive function in all mammals. However, our knowledge of the regulation and possible cellular function of PR protein isoforms in the fallopian tube and uterus in vivo is still very limited. In the present study, we revealed that equine chorionic gonadotropin (eCG) treatment resulted in a time-dependent increase in expression of both isoforms, reaching a maximal level at 48 h in the fallopian tube. Regulation of PR-A protein expression paralleled that of PR-B protein expression. However, in the uterus PR-B protein levels increased and peaked earlier than PR-A protein levels after eCG treatment. With prolonged exposure to eCG, PR-B protein levels decreased, whereas PR-A protein levels continued to increase. Furthermore, subsequent treatment with human (h)CG decreased the levels of PR protein isoforms in both tissues in parallel with increased endogenous serum progesterone levels. To further elucidate whether progesterone regulates PR protein isoforms, we demonstrated that a time-dependent treatment with progesterone (P(4)) decreased the expression of PR protein isoforms in both tissues, whereas decreases in p27, cyclin D(2), and proliferating cell nuclear antigen protein levels were observed only in the uterus. To define the potential PR-mediated effects on apoptosis, we demonstrated that the PR antagonist treatment increased the levels of PR protein isoforms, induced mitochondrial-associated apoptosis, and decreased in epidermal growth factor (EGF) and EGF receptor protein expression in both tissues. Interestingly, immunohistochemistry indicated that the induction of apoptosis by PR antagonists was predominant in the epithelium, whereas increase in PR protein expression was observed in stromal cells of both tissues. Taken together, these observations suggest that 1) the tissue-specific and hormonal regulation of PR isoform expression in mouse fallopian tube and uterus, where they are potentially involved in regulation of mitochondrial-mediated apoptosis depending on the cellular compartment; and 2) a possible interaction between functional PR protein and growth factor signaling may have a coordinated role for regulating apoptotic process in both tissues in vivo.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004963 Estrenes Unsaturated derivatives of the ESTRANES with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17. They must contain one or more double bonds. 19-Norandrostenes,19 Norandrostenes
D005187 Fallopian Tubes A pair of highly specialized canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM transport from the ovaries and they are the site of the ovum's final maturation and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells. Oviducts, Mammalian,Salpinges, Uterine,Salpinx, Uterine,Uterine Salpinges,Uterine Salpinx,Fallopian Tube,Uterine Tubes,Mammalian Oviduct,Mammalian Oviducts,Oviduct, Mammalian,Tube, Fallopian,Tube, Uterine,Tubes, Fallopian,Tubes, Uterine,Uterine Tube
D005260 Female Females

Related Publications

Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
January 2000, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
November 1998, Biology of reproduction,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
August 1994, Nihon Naibunpi Gakkai zasshi,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
April 2003, Contraception,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
September 2002, Reviews in endocrine & metabolic disorders,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
May 2007, Endocrinology,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
April 2000, Biology of reproduction,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
May 2002, Neuroreport,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
May 2010, Fertility and sterility,
Ruijin Shao, and Birgitta Weijdegård, and Karin Ljungström, and Anders Friberg, and Changlian Zhu, and Xiaoyang Wang, and Yihong Zhu, and Julia Fernandez-Rodriguez, and Emil Egecioglu, and Emilia Rung, and Håkan Billig
March 2003, Biology of reproduction,
Copied contents to your clipboard!